Health-care companies rose as traders rotated back into a sector that had fallen out of favor. Shares of insurers such as Humana and UnitedHealth Group added to recent gains following weak performance ...

Hims & Hers HealthHIMS is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second ...

Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Moderately bullish activity in Novo Nordisk (NVO), with shares up 68c, or 1.16%, near $59.70. Options volume relatively light with 42k contracts ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Costco will sell a 4-week supply of Ozempic or Wegovy for $499 out-of-pocket for customers with a valid prescription.

A medical expert has made a case for taking smaller GLP-1 injections, despite manufacturers warning against the practice.

Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David ...

The company, Novo Nordisk, said Friday that prescription-only injectable pens for both drugs will be sold at more than 500 Costco pharmacies in the United States. Executive members and people with ...

Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs.

Costco, which has eight CT stores, has signed a deal with Novo Nordisk to sell Wegovy and Ozempic injections at $499 per month.

A federal appeals court unanimously rejected a Novo Nordisk challenge to Medicare’s drug price negotiation program, a ruling ...